Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Dude51on Apr 20, 2020 10:16am
135 Views
Post# 30929385

One fricken loser, probably selling to himself/herself!

One fricken loser, probably selling to himself/herself!Why would you sell? You bought at a penny and you think this stock is going to tank after all the published reports and patents, trail to cures for symptoms of COVID-19? Makes no sence.imo Well 50% gain on 3000 shares your up 45.00, ooo big spender.


Time ET Ex Price Change Volume Buyer Seller Markers
10:07:43 V 0.015 -0.005 3,000 9 BMO Nesbitt 9 BMO Nesbitt K
09:54:32 U 0.02   5,000 2 RBC 2 RBC K
09:46:13 U 0.02   13,000 124 Questrade 2 RBC K
09:32:32 V 0.02   1,000 79 CIBC 2 RBC K
09:32:32 M 0.02   500 79 CIBC 2 RBC E
09:30:00 V 0.015   800 68 Leede 39 Merrill Lynch  
09:30:00 V 0.02   760 79 CIBC 68 Leede  
09:30:00 V 0.02   9,000 7 TD Sec 2 RBC KL
09:30:00 V 0.02   60,000 7 TD Sec 2 RBC KL
09:30:00 V 0.02   33,000 7 TD Sec 2 RBC KL


<< Previous
Bullboard Posts
Next >>